IRIS Accounts Production v24.3.0.553 08663328 director 1.4.23 31.3.24 31.3.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086633282023-03-31086633282024-03-31086633282023-04-012024-03-31086633282022-03-31086633282022-04-012023-03-31086633282023-03-3108663328ns15:EnglandWales2023-04-012024-03-3108663328ns14:PoundSterling2023-04-012024-03-3108663328ns10:Director12023-04-012024-03-3108663328ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3108663328ns10:Micro-entities2023-04-012024-03-3108663328ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3108663328ns10:FullAccounts2023-04-012024-03-3108663328ns10:RegisteredOffice2023-04-012024-03-3108663328ns5:CurrentFinancialInstruments2024-03-3108663328ns5:CurrentFinancialInstruments2023-03-3108663328ns5:Non-currentFinancialInstruments2024-03-3108663328ns5:Non-currentFinancialInstruments2023-03-31086633281ns10:Director12023-03-31086633281ns10:Director12022-03-31086633281ns10:Director12023-04-012024-03-31086633281ns10:Director12022-04-012023-03-31086633281ns10:Director12024-03-31086633281ns10:Director12023-03-31
REGISTERED NUMBER: 08663328 (England and Wales)



















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

DR GLANCEY CLINICS LIMITED

DR GLANCEY CLINICS LIMITED (BY SHARES) (REGISTERED NUMBER: 08663328)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Balance Sheet 2


DR GLANCEY CLINICS LIMITED (BY SHARES)

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







Director: Dr L Glancey





Registered office: Dickens House
Guithavon Street
Witham
Essex
CM8 1BJ





Registered number: 08663328 (England and Wales)





Accountants: Baverstocks Limited
Chartered Certified Accountants
Dickens House
Guithavon Street
Witham
Essex
CM8 1BJ

DR GLANCEY CLINICS LIMITED (BY SHARES) (REGISTERED NUMBER: 08663328)

BALANCE SHEET
31 MARCH 2024

2024 2023
£    £    £    £   
Fixed assets 100,656 108,296

Current assets 283,176 291,711

Prepayments and accrued income 1,454 3,982

Creditors
Amounts falling due within one year (186,595 ) (99,903 )
Net current assets 98,035 195,790
Total assets less current liabilities 198,691 304,086

Creditors
Amounts falling due after more than one
year

(97,838

)

(131,583

)

Accruals and deferred income (2,000 ) (2,000 )
Net assets 98,853 170,503

Capital and reserves 98,853 170,503

Notes to the financial statements

1. Average number of employees

The average number of employees during the year was 5 (2023 - 3 ) .

2. Director's advances, credits and guarantees

The following advances and credits to a director subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Dr L Glancey
Balance outstanding at start of year 713 -
Amounts advanced 445,595 713
Amounts repaid (341,773 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 104,535 713



DR GLANCEY CLINICS LIMITED (BY SHARES) (REGISTERED NUMBER: 08663328)

BALANCE SHEET - continued
31 MARCH 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 24 October 2024 and were signed by:





Dr L Glancey - Director